ZW19080A1 - Substituted pyranone inhibitors of cholesterol synthesis - Google Patents

Substituted pyranone inhibitors of cholesterol synthesis

Info

Publication number
ZW19080A1
ZW19080A1 ZW190/80A ZW19080A ZW19080A1 ZW 19080 A1 ZW19080 A1 ZW 19080A1 ZW 190/80 A ZW190/80 A ZW 190/80A ZW 19080 A ZW19080 A ZW 19080A ZW 19080 A1 ZW19080 A1 ZW 19080A1
Authority
ZW
Zimbabwe
Prior art keywords
cholesterol synthesis
inhibitors
dihydroxy acids
phenyl
lower alkyl
Prior art date
Application number
ZW190/80A
Other languages
English (en)
Inventor
Edward Jethro Cragoe Jr
Alvin Keith Willard
Frederick Charles Novello
William Freeman Hoffman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZW19080A1 publication Critical patent/ZW19080A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C67/347—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZW190/80A 1979-08-17 1980-08-15 Substituted pyranone inhibitors of cholesterol synthesis ZW19080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6757479A 1979-08-17 1979-08-17

Publications (1)

Publication Number Publication Date
ZW19080A1 true ZW19080A1 (en) 1982-03-17

Family

ID=22076933

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW190/80A ZW19080A1 (en) 1979-08-17 1980-08-15 Substituted pyranone inhibitors of cholesterol synthesis

Country Status (24)

Country Link
EP (1) EP0024348B1 (xx)
JP (1) JPS5645470A (xx)
KR (1) KR840002170B1 (xx)
AT (1) ATE16487T1 (xx)
AU (1) AU6108580A (xx)
CA (1) CA1137989A (xx)
CS (1) CS219921B2 (xx)
DD (1) DD152558A5 (xx)
DE (1) DE3071230D1 (xx)
DK (1) DK353680A (xx)
ES (1) ES8106152A1 (xx)
FI (1) FI802582A (xx)
GR (1) GR69938B (xx)
HU (1) HU182190B (xx)
IE (1) IE50789B1 (xx)
IL (1) IL60751A (xx)
MA (1) MA18929A1 (xx)
NO (1) NO155491C (xx)
NZ (1) NZ194557A (xx)
PL (2) PL127979B1 (xx)
PT (1) PT71672B (xx)
YU (1) YU207180A (xx)
ZA (1) ZA805016B (xx)
ZW (1) ZW19080A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4588820A (en) * 1984-06-11 1986-05-13 Merck & Co., Inc. Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US5169976A (en) * 1987-11-25 1992-12-08 Pfizer Inc. N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
JP3171931B2 (ja) * 1992-06-02 2001-06-04 高砂香料工業株式会社 （Ｒ）−（−）−４−シアノ−３−ヒドロキシ酪酸ｔ−ブチルエステル及びその製造方法
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
RU2563831C1 (ru) * 2014-10-13 2015-09-20 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук Применение протатран 4-хлор-2-метилфеноксиацетата (хлоркрезацина) для угнетения активности холестеролэстеразы
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Also Published As

Publication number Publication date
IL60751A (en) 1985-04-30
NO802431L (no) 1981-02-18
DK353680A (da) 1981-02-19
NZ194557A (en) 1984-09-28
FI802582A (fi) 1981-02-18
DE3071230D1 (en) 1985-12-19
KR830003465A (ko) 1983-06-20
ES494301A0 (es) 1981-07-16
JPH0257550B2 (xx) 1990-12-05
IE801732L (en) 1981-02-17
YU207180A (en) 1983-02-28
CS219921B2 (en) 1983-03-25
NO155491C (no) 1987-04-08
IE50789B1 (en) 1986-07-23
JPS5645470A (en) 1981-04-25
AU6108580A (en) 1981-02-19
EP0024348A1 (en) 1981-03-04
PT71672B (en) 1982-01-22
ATE16487T1 (de) 1985-11-15
PT71672A (en) 1980-09-01
PL226285A1 (xx) 1981-03-27
PL132249B1 (en) 1985-02-28
HU182190B (en) 1983-12-28
CA1137989A (en) 1982-12-21
EP0024348B1 (en) 1985-11-13
KR840002170B1 (ko) 1984-11-26
MA18929A1 (fr) 1981-04-01
NO155491B (no) 1986-12-29
ZA805016B (en) 1982-03-31
IL60751A0 (en) 1980-10-26
ES8106152A1 (es) 1981-07-16
DD152558A5 (de) 1981-12-02
PL127979B1 (en) 1983-12-31
GR69938B (xx) 1982-07-21

Similar Documents

Publication Publication Date Title
ZW19080A1 (en) Substituted pyranone inhibitors of cholesterol synthesis
HU910647D0 (en) Process for producing substituted derivatives of 2-pyridone and pyride-2-thione
WO1991009961A3 (en) Novel products
ES2071016T3 (es) Derivados de piridazinona.
ES8600765A1 (es) Procedimiento de preparar derivados de penicilina
PT72120B (en) Process for preparing 6-(1-hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids
FI881816A (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
HU895422D0 (en) Process for the preparation of 1,4-diazabicyclo [3.2.2] nonane derivatives
IE781734L (en) Preparation of derivatives of benzofuran, chromene and¹isochromene
AU6176586A (en) Intermediates for the production of chromones and thiochromones
HU904596D0 (en) Process for producing lankacidine-carbaminate derivatives